Cohen & Steers (CNS) Earnings Analysis
Cohen & Steers (CNS) next reports earnings on 2026-10-15, consensus EPS 0.95 USD. Last quarter (2026-07-16) it missed with EPS 0.85 USD vs 0.855 USD est (-0.6%). It has beaten estimates in 3/8 recent quarters (38%). Trailing P/E 24.59.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CNS next report earnings?
| Next earnings date | 2026-10-15 |
|---|---|
| Consensus EPS estimate | 0.95 USD |
| Revenue estimate | 0.16B |
CNS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-16 | 0.85 USD | 0.855 USD | -0.6% | Miss |
| 2026-04-16 | 0.79 USD | 0.81 USD | -2.5% | Miss |
| 2026-01-22 | 0.81 USD | 0.81 USD | 0% | Beat |
| 2025-10-16 | 0.81 USD | 0.775 USD | +4.5% | Beat |
| 2025-07-17 | 0.73 USD | 0.75 USD | -2.7% | Miss |
| 2025-04-16 | 0.75 USD | 0.72 USD | +4.2% | Beat |
| 2025-01-22 | 0.78 USD | 0.8 USD | -2.5% | Miss |
| 2024-10-16 | 0.77 USD | 0.78 USD | -1.3% | Miss |
Beat rate: 3/8 (38%) over reported quarters with consensus data.
CNS valuation and analyst view
| Trailing P/E | 24.59 |
|---|---|
| Trailing EPS | 3.265 USD |
| Price / book | 7.36 |
| Dividend yield | 3.21% |
| Market cap | 4.10B |
| Analyst consensus | Sell (4 buy / 4 hold / 5 sell) |
| Avg price target | 83 USD |
Related research pages
Frequently asked questions
When is Cohen & Steers (CNS)'s next earnings date?
Cohen & Steers is next scheduled to report on 2026-10-15, with a consensus EPS estimate of 0.95 USD and revenue estimate of 0.16B.
Did CNS beat earnings last quarter?
In its 2026-07-16 report, CNS posted EPS of 0.85 USD versus a 0.855 USD estimate — a miss of 0.6%.
What is CNS's earnings track record?
Over the last 8 reported quarters with consensus data, CNS beat estimates 3 times (38%).
What is CNS's current P/E ratio and EPS?
CNS trades at a trailing P/E of 24.59 on trailing EPS of 3.265127558444078 USD.
What do analysts rate CNS?
Analyst consensus is "Sell" across 13 ratings (0 strong buy, 4 buy, 4 hold, 5 sell, 0 strong sell). Average 12-month price target: 83 USD.